RGEN FY 2013 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2013 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$68M+9.5% YoY

Gross Profit

$43M63.1% margin

Operating Income

$23M33.6% margin

Net Income

$16M23.6% margin

EPS (Diluted)

$0.50

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$21M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$119M

Total Liabilities

$15M

Stockholders' Equity

$104M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$62M	+9.5%
Gross Profit	$43M	$35M	+22.5%
Operating Income	$23M	$11M	+106.4%
Net Income	$16M	$14M	+13.7%